GeneCentric Therapeutics

GeneCentric Therapeutics is developing the GenomicsNext platform, a liquid biopsy solution designed to provide comprehensive gene expression measurements and high-fidelity DNA variant detection from circulating tumor DNA (ctDNA). This platform aims to provide deeper insights for precision oncology, improving diagnosis and treatment selection by measuring both mutations and gene expression from a single blood sample.

Funding Round: Series C

Funding Amount: $8.0M

Date: 18-Jun-2025

Investors: Hatteras Venture Partners, IAG Capital Partners, Alexandria Venture Investments, Labcorp

Markets: Healthtech, Oncology

HQ: Durham, North Carolina, United States

Founded: 2011

Website: https://www.genecentric.com

LinkedIn: https://www.linkedin.com/company/genecentric

Twitter: https://twitter.com/genecentric

Instagram:

Facebook: